Earnings History Data for Compass Therapeutics, Inc. (CMPX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Compass Therapeutics, Inc.
Compass Therapeutics Inc. is a clinical-stage biopharmaceutical company developing proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematologic malignancies. The company's lead product candidate includes CTX-471. Compass Therapeutics Inc. is based in Boston, MA.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12-11-2024 | PM | CMPX | Compass Therapeutics, Inc. | 248.00 | -0.08 | -0.11 | 0.00 | Compass Therapeutics GAAP EPS of -$0.08 [11/12/2024 11:43 AM] |
1.81 | -0.09 (-4.74%) |
1.90 | 0.0 (0.00%) |
0.76 - 2.34 | 238,011 | 520,000 | 5,663 | ||
| 12-08-2024 | PM | CMPX | Compass Therapeutics, Inc. | 139.00 | -0.10 | -0.10 | 0.00 | Compass Therapeutics GAAP EPS of -$0.10, revenue of $0.85M [8/12/2024 9:06 AM] |
1.14 | 0.05 (4.59%) |
1.15 | 0.06 (5.50%) |
0.76 - 2.58 | 374,586 | 550,000 | 100,415 | ||
| 13-05-2024 | PM | CMPX | Compass Therapeutics, Inc. | 219.00 | -0.08 | -0.11 | 0.00 | Compass Therapeutics GAAP EPS of -$0.08 [5/13/2024 9:01 AM] |
1.56 | -0.04 (-2.50%) |
0.0 | 0.0 (0.00%) |
1.15 - 3.62 | 233,665 | 250,000 | 0 | ||
| 03-08-2023 | PM | CMPX | Compass Therapeutics, Inc. | 339.00 | -0.09 | -0.08 | 0.00 | Compass Therapeutics GAAP EPS of -$0.09 [8/3/2023 10:04 AM] |
2.66 | 0.04 (1.53%) |
0.0 | 0.0 (0.00%) |
1.81 - 5.65 | 212,713 | 380,000 | 0 | ||
| 04-05-2023 | PM | CMPX | Compass Therapeutics, Inc. | 372.00 | -0.06 | -0.11 | 0.00 | Compass Therapeutics GAAP EPS of -$0.06 [5/4/2023 1:22 PM] |
2.95 | -0.05 (-1.67%) |
0.0 | 0.0 (0.00%) |
1.30 - 5.65 | 157,661 | 270,000 | 0 | ||
| 15-03-2023 | PM | CMPX | Compass Therapeutics, Inc. | 442.00 | -0.10 | -0.11 | 0.00 | Compass Therapeutics GAAP EPS of -$0.10 [3/15/2023 9:33 AM] |
3.54 | -0.06 (-1.67%) |
0.0 | 0.0 (0.00%) |
1.25 - 5.65 | 238,137 | 250,000 | 0 | ||
| 09-11-2022 | PM | CMPX | Compass Therapeutics, Inc. | 391.00 | -0.12 | -0.11 | 0.00 | Compass Therapeutics GAAP EPS of -$0.12 misses by $0.01 [11/9/2022 9:35 AM] |
4.21 | -0.04 (-0.94%) |
0.0 | 0.0 (0.00%) |
1.25 - 4.35 | 69,228 | 100,000 | 0 | ||
| 01-08-2022 | PM | 8:00 AM ET (Aug 1) |
CMPX | Compass Therapeutics, Inc. | 257.00 | -0.08 | -0.09 | 0.00 | 2.65 | 0.06 (2.12%) |
0.0 | 0.0 (0.00%) |
1.25 - 4.85 | 54,907 | 120,000 | 0 | ||
|
|
||||||||||||||||||
| 09-05-2022 | PM | CMPX | Compass Therapeutics, Inc. | 152.00 | -0.07 | -0.14 | 0.00 | Compass Therapeutics GAAP EPS of -$0.07 beats by $0.06 [5/9/2022 8:51 AM] |
1.62 | -0.06 (-3.85%) |
1.61 | -0.08 (-4.73%) |
1.25 - 5.92 | 143,172 | 360,000 | 727 | ||
|
||||||||||||||||||